TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - Applications for Research on Tools for Insertional Mutagenesis in the Mouse Requested

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

The National Institute of Neurological Disorders and Stroke (NINDS) requests applications for research on tools for insertional mutagenesis in the mouse. This request is made together with 10 other NIH components.*

The objective of this request for applications (RFA) is to solicit proposals for the development of tools and techniques to establish random and targeted sequence-tagged insertion libraries of embryonic stem (ES) cells that can be used to generate mutant mice in which the expression of the tagged gene could be controlled temporarily and spatially.

Examples of potential areas of research include: feasibility studies for the establishment of sequence-tagged insertional libraries of C57BL/6 ES cells in which the expression of the tagged gene can be controlled temporarily or spatially; development of new or modified site-specific recombination systems for efficient random and targeted insertional mutagenesis and enhanced control of conditional expression; development of novel vectors that allow imaging of specific cell types or tissues, metabolic activity, or other cellular or physiological functions; invention of efficient systems for transposon tagging in mammalian systems for the wide use of the scientific community; development of vectors for identification of promoters and enhancers that could be used for tissue-specific and temporal expression of recombinases and for the study of gene expression patterns; and methods to automate the processing of large numbers of clones and to identify the sites of insertion.


For more information, potential applicants should contact Dr. Gabrielle Leblanc, Program Director, Neurogenetics Cluster, NINDS, Neuroscience Center, 6001 Executive Boulevard, Room 2133, Bethesda, MD 20892; telephone: (301) 496-5745; fax: (301) 402-1501; e-mail:

*For a full list of supporting NIH components and a more detailed description of this RFA, please visit the web site at: